Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2000
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165441 Administering tumor-localizing photosensitizer consisting of a metal phthalocyanine, together with a minor amount of a tracer consisting of said metal phthalocyanine labelled with a radioactive isotope
12/26/2000US6163947 Method of making a hollow-tube brachytherapy device
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076987A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076969A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076550A2 Carrier-drug conjugate
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374616A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/20/2000CN1277633A Mutants of thyroid stimulating hormone and methods based thereon
12/19/2000US6162417 Radioactive halogen-substituted 6-(phenyl)pyrrolo(2,1-a)-isoquinolines; binding to serotonin transporter ligands; tomography imaging, diagnosis/treatment of psychiatric disorders, e.g., obsesive-compulsive; antidepressant; anxiety
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074727A2 Radiopharmaceuticals and methods for imaging
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000045627A3 Radioactive transition metal stents
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/12/2000US6160108 Platelet activation protein
12/12/2000US6159701 Imaging tumor cells in vivo by obtaining sample of monocytes, macrophages, or splenocytes; priming the cells; labeling with radiolabelled a1 adenosine receptor agonist which induces cytotoxicity in the cells; administering to patient
12/12/2000US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000US6159143 Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
12/12/2000US6159142 Stent with radioactive coating for treating blood vessels to prevent restenosis
12/07/2000WO2000074073A1 Sterile radioactive seeds
12/07/2000WO2000073332A1 Annexin derivatives with endogenous chelation sites
12/07/2000WO2000072849A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/07/2000WO2000041514A3 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
12/07/2000CA2377948A1 Annexin derivatives with endogenous chelation sites
12/07/2000CA2375826A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
12/06/2000EP1056860A1 High affinity humanized anti-tag-72 monoclonal antibodies
12/06/2000EP1056859A1 High affinity humanized anti-cea monoclonal antibodies
12/06/2000EP1056773A2 Angiogenesis targeting molecules
12/06/2000EP1056683A2 Process for the selective oxidation of organic compounds
12/06/2000EP1056515A1 Radioactive stent
12/06/2000EP1056503A1 Thin film radiation source
12/05/2000US6156877 Receptor for interleukin-4; has molecular weight of about 200,000 daltons; antitumor agents; immunosuppressants; antibodies
12/05/2000US6156736 Gene transcription and ionizing radiation: methods and compositions
12/04/2000CA2273609A1 Radiopharmaceuticals and methods for imaging
11/2000
11/30/2000WO2000071172A1 Site specific binding system, nuclear imaging compositions and methods
11/30/2000WO2000025829A3 Radiodense compositions
11/30/2000WO2000014119A3 Bifunctional antibodies and their use in targeting anti-tumour agents
11/29/2000EP1054695A2 Soft x-ray emitting medical devices
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/28/2000US6153775 Polydentate imines and their metal complexes
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153172 Reflective microspheres for ultrasonic imaging
11/28/2000US6153170 Administering to a subject, a unit dosage form comprising a radioisotopes of techinium or thallium or gallium or indium absorbed on activated charcoal, employing scintigraphy to measure the colonic transit of the radioisotopes
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA2046308C Radiolabeled colloid compositions, their use and process for their preparation
11/23/2000WO2000069503A1 Methods for forming a radioactive stent
11/23/2000WO2000069474A1 Methods for treating avm' using radioactive compositions
11/23/2000WO2000069473A2 Macromolecular carrier for drug and diagnostic agent delivery
11/23/2000CA2370124A1 Methods for forming a radioactive stent
11/23/2000CA2369983A1 Methods for treating avm's using radioactive compositions
11/22/2000EP1053027A1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi
11/21/2000US6150329 Multimeric antithrombotic agents
11/21/2000US6150155 Kit for providing a technetium medical radioimaging agent
11/21/2000US6149889 Biocompatible ceramic or glass particle comprising calcium phosphate radionuclides which emit beta rays; antitumor agents
11/16/2000WO2000068953A1 Apparatus for the preparation of a radioactive aqueous solution
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067795A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals
11/16/2000WO2000033874B1 Boron neutron capture therapy using pre-targeting methods
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373618A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
11/15/2000EP1051980A2 Dopamine transporter imaging agents
11/15/2000EP1051207A1 Radiopaque implantable collagenous biomaterial device
11/15/2000EP1051206A1 A multi-formed collagenous biomaterial medical device
11/15/2000EP1051195A1 Identification of agents that protect against inflammatory injury to neurons
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/14/2000US6147075 Analgesics; psychological disorders
11/14/2000US6146837 Detecting fc gamma receptor (cd64) in a biological sample by conacting sample with cyanin compound, cy5; illuminating the sample with light of an appropriate excitation wavelength; and detecting fluorescence
11/14/2000US6146614 Administering a labeled ligand to mammal under conditions interact with lymphocytes to form the labeled lymphocytes; for diagnosing the degree of progression of a disease, monitoring the therapy response
11/12/2000CA2721484A1 Dopamine transporter imaging agents
11/09/2000WO2000066537A1 Spect imaging agents for serotonin transporters
11/09/2000WO2000066183A1 Vascular embolic materials having multifunctions
11/09/2000WO2000066182A1 X-ray guided drug delivery
11/09/2000WO2000066091A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000DE19917347A1 Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe Method and apparatus for applying dry substances on inhalable pulverulent carrier substances
11/09/2000CA2372841A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000CA2372481A1 Spect imaging agents for serotonin transporters
11/09/2000CA2368748A1 X-ray guided drug delivery
11/08/2000EP1049718A1 Monoclonal antibody anti alphav-integrin and its use to inhibit alphavbeta6-integrin attachment to fibronectin
11/08/2000EP0727959A4 Diagnostic uses of hydrazinoadenosines
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/07/2000US6143275 Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
11/07/2000US6143274 Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
11/07/2000CA2037933C Method of treatment with medical agents
1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 243